Cargando…
CD137 (4-1BB) Signalosome: Complexity Is a Matter of TRAFs
CD137 (4-1BB, Tnsfr9) is a member of the TNF-receptor (TNFR) superfamily without known intrinsic enzymatic activity in its cytoplasmic domain. Hence, akin to other members of the TNFR family, it relies on the TNFR-Associated-Factor (TRAF) family of adaptor proteins to build the CD137 signalosome for...
Autores principales: | Zapata, Juan M., Perez-Chacon, Gema, Carr-Baena, Pablo, Martinez-Forero, Ivan, Azpilikueta, Arantza, Otano, Itziar, Melero, Ignacio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6262405/ https://www.ncbi.nlm.nih.gov/pubmed/30524423 http://dx.doi.org/10.3389/fimmu.2018.02618 |
Ejemplares similares
-
4-1BB (CD137) in anticancer chimeras
por: Melero, Ignacio, et al.
Publicado: (2020) -
CD137 (4-1BB) costimulation of CD8(+) T cells is more potent when provided in cis than in trans with respect to CD3-TCR stimulation
por: Otano, Itziar, et al.
Publicado: (2021) -
Soluble CD137 as a dynamic biomarker to monitor agonist CD137 immunotherapies
por: Glez-Vaz, Javier, et al.
Publicado: (2022) -
New emerging targets in cancer immunotherapy: CD137/4-1BB costimulatory axis
por: Etxeberria, Iñaki, et al.
Publicado: (2020) -
Essential complicity of perforin-granzyme and FAS-L mechanisms to achieve tumor rejection following treatment with anti-CD137 mAb
por: Morales-Kastresana, Aizea, et al.
Publicado: (2013)